Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000932471-24-000983
Filing Date
2024-11-12
Accepted
2024-11-12 14:31:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 UnitedStates_13G__EyePointPh.txt SC 13G/A 5010
  Complete submission text file 0000932471-24-000983.txt   6791
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address 100 VANGUARD BLVD MALVERN PA 19355 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

EIN.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Subject) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81613 | Film No.: 241447011
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)